LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 283 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 6.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $833,000 | -9.3% | 7,300 | 0.0% | 0.31% | -8.8% |
| Q1 2019 | $918,000 | -84.7% | 7,300 | -87.0% | 0.34% | -90.9% |
| Q4 2018 | $5,998,000 | -18.5% | 56,300 | +60.9% | 3.72% | +6.4% |
| Q3 2018 | $7,363,000 | +1.6% | 35,000 | 0.0% | 3.50% | +25.7% |
| Q2 2018 | $7,250,000 | +4.5% | 35,000 | -16.7% | 2.78% | +2.9% |
| Q1 2018 | $6,936,000 | +74.7% | 42,000 | +44.8% | 2.71% | +93.3% |
| Q4 2017 | $3,971,000 | +0.6% | 29,000 | 0.0% | 1.40% | -8.9% |
| Q3 2017 | $3,946,000 | +261.0% | 29,000 | +222.2% | 1.54% | +270.1% |
| Q2 2017 | $1,093,000 | +14.8% | 9,000 | 0.0% | 0.42% | +14.0% |
| Q1 2017 | $952,000 | -68.8% | 9,000 | -70.0% | 0.36% | -73.5% |
| Q4 2016 | $3,048,000 | – | 30,000 | – | 1.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |